Диссертация (1173234), страница 23
Текст из файла (страница 23)
– р.733–736.160. Delitala, A.P. Thyroid Hormones, Metabolic Syndrome and Its Components /A.P. Delitala, G. Fanciulli, G.M. Pes [et al.] // Endocr Metab Immune Disord DrugTargets. – 2017. – V.17(1). – р.56-62.161. De Luca, N. REASON Project Investigators. Selective reduction of cardiac massand central blood pressure on low-dose combination perindopril/indapamide inhypertensive subjects / N.
De Luca, R.G. Asmar, G.M. London [et al.] // J.Hypertension. – 2004. – 8. – p.1623-1630.162. Duntas, L. H. New insights into subclinical hypothyroidism and cardiovascularrisk / L. H. Duntas, B. Biondi // Semin. Thromb. Hemost. -2011. - 37(1). – р.27–34.163. Duntas, L.H. The effect of thyroid disorders on lipid levels and metabolism /L.H.
Duntas, G. Brenta // Med. Clin. North. Am. – 2012. - 96(2). – р.269–281.164. Ferrier, K.E. Intensive cholesterol reduction lowers blood pressure and largeartery stiffness in isolated systolic hypertension / K.E. Ferrier, M.H. Muhlmann, J.P. [etal.] // Baguet J Am Coll Cardiol. – 2002. – 39. – р.1020–1025.165. Hamano, K. Increased risk for atherosclerosis estimated by pulse wave velocity inhypothyroidism and its reversal with appropriate thyroxine treatment / K.
Hamano, M.Inoue // Endocr J. – 2005. – V.52, №1. – р. 95-101.166. Handisurya, A. Effects of thyroxine replacement therapy on glucose metabolismin subjects with subclinical and overt hypothyroidism / A. Handisurya, G. Pacini, A.Tura [et al.] // Clin. Endocrinol. (Oxf.). — 2008. — № 69(6). — р.963-969.167. Herbert, А. Establishing reference values for central blood pressure and itsamplification in a general healthy population and according to cardiovascular riskfactors / A. Herbert, J. K.
Cruickshank, S. Laurent [et al.] // European Heart Journal. –2014. – 35(44). – р.3122-3132.168. Gao, N.Carotidintimamediathicknessinpatientswithsubclinicalhypothyroidism / N. Gao, W. Zhang, Y.Z. Zhang [et al.] // Eur Thyroid J. - 2012. - 26. 431-446.137169. Gencer, B. Thyroid Studies Collaboration. Subclinical thyroid dysfunction andthe risk of heart failure events: an individual participant data analysis from 6prospective cohorts / B.
Gencer, T.H. Collet, V. Virgini [et al.] // Circulation. – 2012. 126(9). – р.1040–1049.170. Ghiadoni, L. Combination therapy with lercanidipine and enalapril reducedcentral blood pressure augmentation in hypertensive patients with metabolic syndrome/ L. Ghiadoni, R.M. Bruno, G. Cartoni [et al.] // Vascul Pharmacol. – 2017. – V.92. –р.16-21.171. Gonzalez, Gil L.
Prevalence of hypertension and other cardiovascular risk factorsin subjects with subclinical hypothyroidism / Gil L. Gonzalez, A. de la Sierra // MedClin (Barc). – 2017. – V.148(8). – р.351-353.172. Gosse, P. Regression of left ventricular hypertrophy in hypertensive patientstreated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study / P.
Gosse,D.J. Sheridan, F. Zannad [et al.] // J. Hypertens. – 2000. - 18(10). –р.1465–1475.173. Guzel, S. Visfatin, Leptin, and TNF-β: Interrelated Adipokines in InsulinResistant Clinical and Subclinical Hypothyroidism / S. Guzel, A. Seven, E.C.
Guzel [etal.] // Endocr. Res.- 2014. - 4 (9). – р.147—153.174. Handisurya, A. Effects of thyroxine replacement therapy on glucose metabolismin subjects with subclinical and overt hypothyroidism / A. Handisurya, G. Pacini, A.Tura [et al.] // Clin. Endocrinol. (Oxf.). — 2008. — № 69(6). — р.963–969.175. Hernández-Mijares, A. Relation between lipoprotein subfractions and TSH levelsin the cardiovascular risk among women with subclinical hypothyroidism / A.Hernández-Mijares, A.
Jover, L. Bellod [et al.] //Clin. Endocrinol. – 2013. -78(5). –р.777–782.176. Hofman, A. The Rotterdam Study: 2014 objectives and design update / A.Hofman, S. Darwish Murad, C.M. van Duijn [et al.] // Eur. J. Epidemiol. – 2013. 28(11). – р.889–926.177. Huveneers, S. Between Rho(k) and a hard place: the relation between vessel wallstiffness, endothelial contractility, and cardiovascular disease / S. Huveneers, M.J.Daemen, P.L. Hordijk // Circ Res. – 2015.
– 116. – р.895-908.138178. Kangas, P. Metabolic syndrome may be associated with increased arterialstiffness even in the absence of hypertension: a study in 84 cases and 82 controls / P.Kangas [et al.] // Diabet Med. – 2009. – V.26, №4. – р.354-361.179. Kannel, W.B. Left ventricular hypertrophy as a risk factor in arterial hypertension/ W.B. Kannel // Eur Heart J. - 1992. - Vol. 13. - р.82-88.180. Kass, DA. Improved arterial compliance by a novel advanced glycation endproduct crosslink breaker / D.A. Kass, E.P. Shapiro, М. Kawaguchi [et al.] //Circulation 2001.
– 104. – р.1464–1470.181. Khan,S.H.InsulinResistanceandGlucoseLevelsinSubjectswith Subclinical Hypothyroidism / S.H. Khan, N. Fazal, A. Ijaz [et al.] // J CollPhysicians Surg Pak. – 2017. – V.27(6). – р.329-333.182. Kida, Y. Sirtuins, cell senescence, and vascular aging / Y. Kida, M.S. Goligorsky// Can J Cardiol. – 2016. – 32. – р.634-641.183. Kidawa, М. Arterial dysfunction in syndrome X: results of arterial reactivity andpulse wave propagation tests / M. Kidawa, M. Krzeminska-Pakula, J. Z. Peruga [ et al.]// Heart. – 2003. – V.89, № 4.
– P. 422-426.184. Kim, S. Normal-weight obesity is associated with increased risk of subclinicalatherosclerosis / S. Kim, C. Kyung, J.S. Park [ et al.] // Cardiovascular Diabetology.2015.- V.14(58).- р.1-9.185. Klein, I. Thyroid disease and the heart / I. Klein, S. Danzi // Circulation. 2007. Vol.116(15). - р.1725–1735.186.
Klieverik, L.P. Thyroid hormone modulates glucose production via a sympatheticpathway from the hypothalamic paraventricular nucleus to the liver / Klieverik L.P.,Janssen S.F., van Riel A. [et al.] // Proc. Natl. Acad. Sci. U. S. A.
— 2009. — № 106.— р. 5966–5971.187. Kontopoulos, A.G. Long-term treatment effect of atorvastatin on aortic stiffnessin hypercholesterolaemic patients / A.G. Kontopoulos, V.G. Athyros, A.N. Pehlivanidis[et al.] // Curr Med Res Opin. – 2003. – 19. – р.22–27.139188. Koskinen, T. Metabolic syndrome and short-term heart rate variability in youngadults. The cardiovascular risk in young Finns study / T. Koskinen [ et al.] //Metabolism.
– 2013. – V.62, № 8. – р.1114-1122.189. Kotsis, V. Early vascular aging and the role of central blood pressure / V. Kotsis,S. Stabouli, I. Karafillis [et al.] // J. Hypertens. – 2011. – 29. – р.1847-1853.190. Koumaras, C. Role of antihypertensive drugs in arterial “de-stiffening” andcentral pulsatile hemodynamics / C, Koumaras, M. Tzimou, E. Stavrinou [et al.] // Am JCardiovasc Drugs. - 2012.- 12(3). - 143-156.191. Kvetny, J.Sublinicalhypothyroidismisassociatedwithalow-gradeinflammation, increased triglyceride levels and predicts cardiovascular disease in malesbellow 50 yars / J.
Kvetny, P.E. Heldgaard, E.M. Bladbjerg // Gram J.Clin Endocrinol(Oxf). – 2004. – 61. – с.232–238.192. Lambrinoudaki, I. High normal thyroid-stimulating hormone is associated witharterial stiffness in healthy postmenopausal women / I. Lambrinoudaki, E.
Armeni, G.Georgiopoulos [et al.] // J Hypertens. – 2012. – 30(3). – р.592-599.193. Laragh, J.H. Relevance of the plasma renin hormonal control system thatregulates blood pressure and sodium balance for correctly treating hypertension and forevaluating ALLHAT / J.H. Laragh, J.E. Sealey // Am. J. Hypertens. 2003. - Vol.16.
р.407–415.194. Laugesen, E. Arterial Stiffness and Central Hemodynamics in ThyroidectomizedPatients on Long-Term Substitution Therapy with Levothyroxine / E. Laugesen, E.Moser, T. Sikjaer [et al.] // Thyroid. – 2016. - V. 26 (6). – р.779-784.195. Laurent, S. Aortic stiffness is an independent predictor of all-cause andcardiovascular mortality in hypertensive patients / S. Laurent, P. Boutouyrie, R. Asmar[et al.] // Hypertension. – 2001. - №37.
– p.1236-1241.196. Laurent, S. The structural factor of hypertension: large and small arteryalterations / S. Laurent, P. Boutouyrie // Circ Res. – 2015. – 116. – р.1007-1021.197. Le, T. N. Thyrotropin levels are associated with cardiometabolic risk factors ineuthyroid adolescents / T. N. Le, F.S. Celi, E.P.
Wickham // Thyroid. – 2016. – V.26(10). – р.1441–1449.140198. Lee, Y.K. Serum TSH level in healthy Koreans and the association of TSH withserum lipid concentration and metabolic syndrome / Y.K. Lee, J.E. Kim, H.J. Oh [et al.]// Korean J Intern Med. – 2011. – V.26, №4.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
